Windrose Health Investors Invests In Terrapin Pharmacy
01/05/22, 7:00 AM
WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Terrapin Pharmacy LLC ("Terrapin" or the "Company"), a leading specialized pharmacy offering high-touch, value-added distribution and medication adherence services and technology. The Company primarily serves patients with severe and persistent mental illness (SPMI), intellectual and developmental disabilities (IDD), and substance abuse disorders. Terms of the transaction were not disclosed.
Company Info
Additional Info
Terrapin Pharmacy is a closed-door specialized pharmacy that primarily serves individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region. The Company serves this population through high-touch distribution relationships with community-based behavioral health agencies and long-term care facilities, enabling improved medication adherence and care management for complex and costly patient populations.